{"id":"placebo-d5w","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hyponatremia (with prolonged use)"},{"rate":null,"effect":"Phlebitis at infusion site"}]},"_chembl":{"chemblId":"CHEMBL1222250","moleculeType":"Small molecule","molecularWeight":"180.16"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"D5W is a crystalloid solution containing 5% dextrose dissolved in sterile water. It is administered intravenously to maintain fluid balance, provide basic caloric support, and deliver medications. As a placebo in clinical trials, it serves as an inactive comparator with no active pharmacological mechanism.","oneSentence":"D5W (dextrose 5% in water) is an intravenous fluid that provides hydration and a modest amount of glucose for energy.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:38.738Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Used as a placebo control in clinical trials"}]},"trialDetails":[{"nctId":"NCT07224711","phase":"PHASE4","title":"The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2026-07-01","conditions":"Pain, Post Operative Analgesia, Opioid Consumption, Postoperative","enrollment":2290},{"nctId":"NCT06611111","phase":"EARLY_PHASE1","title":"Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease","status":"RECRUITING","sponsor":"State University of New York - Upstate Medical University","startDate":"2025-02-03","conditions":"Post-Treatment Lyme Disease","enrollment":44},{"nctId":"NCT04918719","phase":"PHASE2","title":"Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2023-11-02","conditions":"Acute Ischemic Stroke","enrollment":4},{"nctId":"NCT04096170","phase":"PHASE4","title":"Improving Pain Control in Paraesophageal Hernia Repair: Intravenous Lidocaine Versus Placebo","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2018-06-21","conditions":"Hernia, Paraesophageal","enrollment":50},{"nctId":"NCT06785402","phase":"PHASE1, PHASE2","title":"Ceftriaxone for Post-Treatment Lyme Disease","status":"RECRUITING","sponsor":"Hackensack Meridian Health","startDate":"2026-02-15","conditions":"Post-Treatment Lyme Disease Syndrome","enrollment":20},{"nctId":"NCT07343206","phase":"NA","title":"Early Norepinephrine Administration and Rapid Dose Adjustment","status":"NOT_YET_RECRUITING","sponsor":"Siriraj Hospital","startDate":"2026-01","conditions":"Sepsis, Septic Shock","enrollment":600},{"nctId":"NCT03608033","phase":"PHASE3","title":"Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy","status":"TERMINATED","sponsor":"Omeros Corporation","startDate":"2018-04-05","conditions":"IgA Nephropathy","enrollment":360},{"nctId":"NCT05517668","phase":"PHASE2","title":"Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose","status":"TERMINATED","sponsor":"Richard Dart, MD, PhD","startDate":"2022-09-12","conditions":"Acetaminophen, Drug Overdose, Acetaminophen Overdose","enrollment":29},{"nctId":"NCT02951130","phase":"PHASE2","title":"Milrinone in Congenital Diaphragmatic Hernia","status":"COMPLETED","sponsor":"NICHD Neonatal Research Network","startDate":"2017-10-24","conditions":"Congenital Diaphragmatic Hernia, Persistent Pulmonary Hypertension of the Newborn, Hypoxemic Respiratory Failure","enrollment":66},{"nctId":"NCT06863467","phase":"PHASE1, PHASE2","title":"Evaluation of the Safety and Tolerability of Gemini in Subjects With Stage 3-4 Chronic Kidney Disease.","status":"COMPLETED","sponsor":"Revelation Biosciences, Inc","startDate":"2025-01-20","conditions":"Renal Insufficiency, Chronic, Chronic Kidney Disease stage3, Chronic Kidney Disease stage4","enrollment":40},{"nctId":"NCT06039566","phase":"PHASE3","title":"NAC vs Placebo on Opioid Use for Hysterectomy","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2023-11-30","conditions":"Hysterectomy","enrollment":240},{"nctId":"NCT04138394","phase":"PHASE3","title":"VItamin C in Thermal injuRY: The VICToRY Trial","status":"SUSPENDED","sponsor":"Clinical Evaluation Research Unit at Kingston General Hospital","startDate":"2020-07-24","conditions":"Shock, Thermal Burn","enrollment":666},{"nctId":"NCT04082533","phase":"PHASE4","title":"Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2019-07-24","conditions":"Pain, Arthrofibrosis, Osteoarthritis, Knee","enrollment":132},{"nctId":"NCT04603066","phase":"PHASE1, PHASE2","title":"Tariquidar-ondansetron Combination in Neuropathic Pain","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2021-01-31","conditions":"Neuropathic Pain","enrollment":24},{"nctId":"NCT01746979","phase":"PHASE3","title":"Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma","status":"COMPLETED","sponsor":"ImmunoGenesis","startDate":"2012-12","conditions":"Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma","enrollment":693},{"nctId":"NCT04935359","phase":"PHASE3","title":"Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-09-30","conditions":"Metastatic Pancreatic Ductal Adenocarcinoma","enrollment":511},{"nctId":"NCT03019653","phase":"PHASE1","title":"Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-01","conditions":"Heart Failure, Cardiorenal Disease, Renal Disfunction","enrollment":40},{"nctId":"NCT04323436","phase":"PHASE2","title":"Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2020-08-19","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":31},{"nctId":"NCT05967442","phase":"PHASE3","title":"Magnesium Versus Prochlorperazine Versus Metoclopramide for Migraines","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2019-08-23","conditions":"Migraine, Headache","enrollment":157},{"nctId":"NCT03102606","phase":"PHASE3","title":"Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3","status":"COMPLETED","sponsor":"BeyondSpring Pharmaceuticals Inc.","startDate":"2018-05-29","conditions":"Chemotherapy-induced Neutropenia","enrollment":105},{"nctId":"NCT01969409","phase":"PHASE2","title":"Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2014-01","conditions":"Ambulatory IPF","enrollment":58},{"nctId":"NCT02112656","phase":"PHASE3","title":"Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)","status":"COMPLETED","sponsor":"Imunon","startDate":"2014-06","conditions":"Hepatocellular Carcinoma","enrollment":554},{"nctId":"NCT04799249","phase":"PHASE3","title":"Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)","status":"COMPLETED","sponsor":"G1 Therapeutics, Inc.","startDate":"2021-05-14","conditions":"TNBC - Triple-Negative Breast Cancer, Breast Cancer","enrollment":194},{"nctId":"NCT06509880","phase":"PHASE1, PHASE2","title":"Immunosurveillance for Metastatic Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"MIPO Clinic","startDate":"2024-07-15","conditions":"Monitoring, Immunologic","enrollment":200},{"nctId":"NCT03802435","phase":"NA","title":"Different Sessions of Perineural Injection With Dextrose for Carpal Tunnel Syndrome","status":"COMPLETED","sponsor":"Tri-Service General Hospital","startDate":"2019-08-01","conditions":"Carpal Tunnel Syndrome","enrollment":30},{"nctId":"NCT02925416","phase":"PHASE4","title":"Safety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and Skin Structure Infection","status":"COMPLETED","sponsor":"The Medicines Company","startDate":"2017-01-24","conditions":"Skin Diseases, Bacterial","enrollment":22},{"nctId":"NCT04404387","phase":"PHASE3","title":"Lessening Organ Dysfunction With VITamin C in Septic ARDS","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-07-22","conditions":"Septic, Acute Respiratory Distress Syndrome","enrollment":800},{"nctId":"NCT02470702","phase":"PHASE1","title":"Multiple Oritavancin Doses on Safety, Tolerability, and Pharmacokinetics in Healthy Subjects","status":"COMPLETED","sponsor":"Melinta Therapeutics, Inc.","startDate":"2015-06","conditions":"Healthy","enrollment":14},{"nctId":"NCT02471690","phase":"PHASE1","title":"Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a New Formulation of Oritavancin in Healthy Volunteers","status":"COMPLETED","sponsor":"The Medicines Company","startDate":"2015-07","conditions":"Healthy","enrollment":56},{"nctId":"NCT03586089","phase":"NA","title":"Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome","status":"TERMINATED","sponsor":"Unity Health Toronto","startDate":"2021-06-11","conditions":"Alcohol Withdrawal Delirium, Alcohol Withdrawal, Alcohol Withdrawal Seizures","enrollment":8},{"nctId":"NCT03829683","phase":"PHASE2","title":"Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2019-04-16","conditions":"Alcoholic Hepatitis, Sepsis","enrollment":20},{"nctId":"NCT04294472","phase":"PHASE2","title":"A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Vera Therapeutics, Inc.","startDate":"2020-08-05","conditions":"BK Virus Infection","enrollment":30},{"nctId":"NCT04401150","phase":"PHASE3","title":"Lessening Organ Dysfunction With VITamin C - COVID-19","status":"COMPLETED","sponsor":"Université de Sherbrooke","startDate":"2020-08-14","conditions":"Vitamin C, COVID-19, Hospitalized Patients","enrollment":392},{"nctId":"NCT04863248","phase":"PHASE2","title":"Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4)","status":"TERMINATED","sponsor":"G1 Therapeutics, Inc.","startDate":"2021-04-30","conditions":"Metastatic Non-Small Cell Lung Cancer, NSCLC, Lung Cancer","enrollment":10},{"nctId":"NCT03617289","phase":"NA","title":"Efficacy of Magnesium Sulfate on Reducing Renal Colic in the Emergency Department","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2016-01","conditions":"Renal Colic","enrollment":37},{"nctId":"NCT01376778","phase":"PHASE3","title":"A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)","status":"COMPLETED","sponsor":"The George Washington University Biostatistics Center","startDate":"2012-04","conditions":"Congenital Cytomegalovirus Infection, Maternal Cytomegalovirus Infection","enrollment":399},{"nctId":"NCT05349760","phase":"PHASE2","title":"A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis","status":"WITHDRAWN","sponsor":"AmMax Bio, Inc.","startDate":"2023-03","conditions":"IPF","enrollment":""},{"nctId":"NCT03809234","phase":"PHASE1","title":"Pgp Transporter and CNS Biodistribution of Ondansetron in Healthy Volunteers","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2019-05-20","conditions":"Neuropathic Pain","enrollment":14},{"nctId":"NCT03254394","phase":"PHASE1, PHASE2","title":"Lidocaine for Oxaliplatin-induced Neuropathy","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-09-15","conditions":"Neuropathy, Painful, Chemotherapy-induced Peripheral Neuropathy, Colorectal Cancer","enrollment":26},{"nctId":"NCT03130790","phase":"PHASE2, PHASE3","title":"Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)","status":"COMPLETED","sponsor":"ASLAN Pharmaceuticals","startDate":"2017-08-31","conditions":"Gastric Cancer","enrollment":52},{"nctId":"NCT02802228","phase":"PHASE2","title":"Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients","status":"COMPLETED","sponsor":"Cumberland Pharmaceuticals","startDate":"2017-03-06","conditions":"Portal Hypertension, Liver Cirrhosis","enrollment":30},{"nctId":"NCT03089671","phase":"NA","title":"Ureteric Visualization: Vitamin B Vs 5% Dextrose in Water","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2017-12-07","conditions":"Pelvic Floor Disorders, Ureter; Kink","enrollment":238},{"nctId":"NCT02592798","phase":"PHASE2","title":"Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2016-03-09","conditions":"Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Minimal Change Disease","enrollment":36},{"nctId":"NCT03294577","phase":"PHASE3","title":"Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia","status":"UNKNOWN","sponsor":"BeyondSpring Pharmaceuticals Inc.","startDate":"2019-10-23","conditions":"Chemotherapy-induced Neutropenia","enrollment":221},{"nctId":"NCT01778634","phase":"PHASE2","title":"Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2013-07","conditions":"Ureaplasma Infections","enrollment":121},{"nctId":"NCT01167569","phase":"PHASE4","title":"Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2007-10","conditions":"Reperfusion Injury","enrollment":57},{"nctId":"NCT02100748","phase":"PHASE2","title":"A Study of TRV130 for the Treatment of Pain After Bunionectomy","status":"COMPLETED","sponsor":"Trevena Inc.","startDate":"2014-04","conditions":"Acute Pain","enrollment":333},{"nctId":"NCT02335294","phase":"PHASE2","title":"A Study of TRV130 for the Treatment of Pain After Abdominoplasty","status":"COMPLETED","sponsor":"Trevena Inc.","startDate":"2014-12","conditions":"Pain","enrollment":200},{"nctId":"NCT02267317","phase":"PHASE2","title":"The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic Subjects","status":"TERMINATED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2015-01","conditions":"Insulin Sensitivity","enrollment":15},{"nctId":"NCT01384877","phase":"PHASE2, PHASE3","title":"Subcutaneous Lidocaine For Cancer-Related Pain","status":"COMPLETED","sponsor":"British Columbia Cancer Agency","startDate":"2011-12","conditions":"Cancer-related Pain","enrollment":33},{"nctId":"NCT02103998","phase":"PHASE3","title":"Study of Thyroid Hormones in Prematures","status":"WITHDRAWN","sponsor":"New York Medical College","startDate":"2020-07-01","conditions":"Transient Hypothyroxinemia of Prematurity (THOP)","enrollment":""},{"nctId":"NCT02623803","phase":"PHASE4","title":"Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2016-01","conditions":"Pancreatectomy","enrollment":48},{"nctId":"NCT03148236","phase":"PHASE2","title":"Vitamin C in Atrial Fibrillation Ablation","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2017-09-18","conditions":"Atrial Fibrillation Ablation","enrollment":20},{"nctId":"NCT01409031","phase":"PHASE2","title":"Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2011-07","conditions":"Persistent Pulmonary Hypertension, Respiratory Failure","enrollment":3},{"nctId":"NCT00781768","phase":"PHASE4","title":"Odansetron and Dexamethasone Alone vs. Odansetron, Dexamethason and Apreptant to Prevent Nausea","status":"COMPLETED","sponsor":"Loyola University","startDate":"2003-08","conditions":"Nausea, Vomiting","enrollment":181},{"nctId":"NCT00543309","phase":"PHASE2","title":"Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery","status":"TERMINATED","sponsor":"John M Costello","startDate":"2007-10","conditions":"Heart Defects, Congenital","enrollment":106},{"nctId":"NCT01638104","phase":"PHASE1","title":"ANX-042 Healthy Volunteer Dose Escalation Study","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2012-08","conditions":"Healthy Volunteers","enrollment":30},{"nctId":"NCT01811732","phase":"PHASE3","title":"Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections","status":"COMPLETED","sponsor":"Melinta Therapeutics, Inc.","startDate":"2013-04","conditions":"Skin and Subcutaneous Tissue Bacterial Infections","enrollment":660},{"nctId":"NCT00609245","phase":"PHASE4","title":"Effect of Valproic Acid Concentration on Photic Response","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2007-12","conditions":"Photosensitive Epilepsy","enrollment":13},{"nctId":"NCT01474863","phase":"PHASE2","title":"Citrulline in Severe Sepsis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2012-08","conditions":"Severe Sepsis, Acute Lung Injury","enrollment":72},{"nctId":"NCT00874393","phase":"PHASE1","title":"Early Blood Pressure Management in Extremely Premature Infants","status":"COMPLETED","sponsor":"NICHD Neonatal Research Network","startDate":"2009-07","conditions":"Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age","enrollment":10},{"nctId":"NCT01174290","phase":"PHASE4","title":"Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol","status":"COMPLETED","sponsor":"Northeastern University","startDate":"2010-09","conditions":"Subsyndromal Delirium","enrollment":68},{"nctId":"NCT01436500","phase":"PHASE2","title":"Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients","status":"COMPLETED","sponsor":"Cumberland Pharmaceuticals","startDate":"2011-10","conditions":"Hepatorenal Syndrome","enrollment":55},{"nctId":"NCT03024814","phase":"PHASE3","title":"Prophylactic Acetaminophen for Prevention Intraventricular Hemorrhage in Premature Infants","status":"UNKNOWN","sponsor":"King Saud Medical City","startDate":"2016-10","conditions":"Intraventricular Haemorrhage Neonatal","enrollment":300},{"nctId":"NCT01750905","phase":"PHASE1","title":"Safety Study of Chimeric Natriuretic Peptide(CD-NP) in Stable LVAD Patients","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2013-04","conditions":"Left Ventricular Insufficiency","enrollment":14},{"nctId":"NCT00248625","phase":"PHASE3","title":"N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2000-01","conditions":"Acute Liver Failure, Hepatic Encephalopathy","enrollment":184},{"nctId":"NCT00809055","phase":"PHASE4","title":"MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2008-11","conditions":"Apnea of Prematurity, Intraventricular Hemorrhage, Brain Injury","enrollment":74},{"nctId":"NCT01605279","phase":"PHASE2","title":"Dobutamine Versus Placebo for Low Superior Vena Cava Flow in Newborns","status":"COMPLETED","sponsor":"Adelina Pellicer","startDate":"2010-09","conditions":"Hemodynamic Instability","enrollment":127},{"nctId":"NCT01407900","phase":"PHASE1","title":"Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction","status":"WITHDRAWN","sponsor":"John A. Schirger","startDate":"2014-01","conditions":"Heart Failure, Renal Insufficiency","enrollment":""},{"nctId":"NCT00680706","phase":"PHASE2","title":"Thiamine and Acute Decompensated Heart Failure: Pilot Study","status":"COMPLETED","sponsor":"Baystate Medical Center","startDate":"2008-01","conditions":"Heart Failure, Diabetes","enrollment":131},{"nctId":"NCT00409838","phase":"PHASE3","title":"A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2007-04","conditions":"Rheumatoid Arthritis","enrollment":113},{"nctId":"NCT01260883","phase":"PHASE3","title":"Ketorolac in Postoperative Infants: Pharmacokinetics and Safety","status":"COMPLETED","sponsor":"Seattle Children's Hospital","startDate":"2000-05","conditions":"Postoperative Pain in Infants","enrollment":77},{"nctId":"NCT01825473","phase":"NA","title":"Study of Erythromycin in GER-Associated Apnea of the Newborn","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2012-09","conditions":"Gastroesophageal Reflux, Apnea, Bradycardia","enrollment":40},{"nctId":"NCT01617577","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Filgrastim in Alzheimer's Disease","status":"COMPLETED","sponsor":"University of South Florida","startDate":"2009-06","conditions":"Alzheimer's Disease","enrollment":8},{"nctId":"NCT01291654","phase":"PHASE2","title":"Paracetamol and Patent Ductus Arteriosus (PDA)","status":"UNKNOWN","sponsor":"Shaare Zedek Medical Center","startDate":"2012-04","conditions":"Patent Ductus Arteriosus","enrollment":80},{"nctId":"NCT00612014","phase":"PHASE2","title":"Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis","status":"COMPLETED","sponsor":"Tranzyme, Inc.","startDate":"2007-10","conditions":"Gastroparesis, Diabetes Mellitus","enrollment":78},{"nctId":"NCT00617552","phase":"PHASE2","title":"Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery","status":"COMPLETED","sponsor":"Tranzyme, Inc.","startDate":"2007-07","conditions":"Postoperative Ileus","enrollment":267},{"nctId":"NCT00391911","phase":"PHASE2","title":"Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis","status":"COMPLETED","sponsor":"Royal Alexandra Hospital","startDate":"2006-11","conditions":"Rhabdomyolysis","enrollment":3},{"nctId":"NCT00374088","phase":"PHASE2","title":"N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study)","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2005-02","conditions":"Transposition of Great Vessels, Congenital Heart Disease","enrollment":21},{"nctId":"NCT00048568","phase":"PHASE3","title":"A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2002-12","conditions":"Rheumatoid Arthritis","enrollment":1250},{"nctId":"NCT00048932","phase":"PHASE3","title":"A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2002-12","conditions":"Rheumatoid Arthritis","enrollment":1795},{"nctId":"NCT01326611","phase":"PHASE4","title":"Efficacy of Clarithromycin Treatment in Prevention of Chronic Lung Disease in Premature Infants","status":"COMPLETED","sponsor":"Zekai Tahir Burak Women's Health Research and Education Hospital","startDate":"2008-05","conditions":"Chronic Lung Disease","enrollment":273},{"nctId":"NCT00668759","phase":"PHASE3","title":"A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation","status":"COMPLETED","sponsor":"Advanz Pharma","startDate":"2008-04","conditions":"Atrial Fibrillation","enrollment":254},{"nctId":"NCT00830193","phase":"PHASE2, PHASE3","title":"N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2002-08","conditions":"Contrast Induced Nephropathy, Critically Ill","enrollment":45},{"nctId":"NCT00639808","phase":"PHASE1","title":"Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis","status":"COMPLETED","sponsor":"Tranzyme, Inc.","startDate":"2006-08","conditions":"Gastroparesis, Diabetes Mellitus","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":25,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["5% dextrose in water","Placebo, Vehicle","D5W"],"phase":"marketed","status":"active","brandName":"Placebo (D5W)","genericName":"Placebo (D5W)","companyName":"The Medicines Company","companyId":"the-medicines-company","modality":"Small molecule","firstApprovalDate":"","aiSummary":"D5W (dextrose 5% in water) is an intravenous fluid that provides hydration and a modest amount of glucose for energy. Used for Used as a placebo control in clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}